227 related articles for article (PubMed ID: 19785513)
1. Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues.
Myllynen P; Immonen E; Kummu M; Vähäkangas K
Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1483-99. PubMed ID: 19785513
[TBL] [Abstract][Full Text] [Related]
2. The role of the placenta in fetal exposure to xenobiotics: importance of membrane transporters and human models for transfer studies.
Prouillac C; Lecoeur S
Drug Metab Dispos; 2010 Oct; 38(10):1623-35. PubMed ID: 20606001
[TBL] [Abstract][Full Text] [Related]
3. Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: a resource for investigations into drug disposition.
Bleasby K; Castle JC; Roberts CJ; Cheng C; Bailey WJ; Sina JF; Kulkarni AV; Hafey MJ; Evers R; Johnson JM; Ulrich RG; Slatter JG
Xenobiotica; 2006; 36(10-11):963-88. PubMed ID: 17118916
[TBL] [Abstract][Full Text] [Related]
4. Placental drug transporters and their role in fetal protection.
Iqbal M; Audette MC; Petropoulos S; Gibb W; Matthews SG
Placenta; 2012 Mar; 33(3):137-42. PubMed ID: 22265855
[TBL] [Abstract][Full Text] [Related]
5. Xenobiotic transporters: ascribing function from gene knockout and mutation studies.
Klaassen CD; Lu H
Toxicol Sci; 2008 Feb; 101(2):186-96. PubMed ID: 17698509
[TBL] [Abstract][Full Text] [Related]
6. Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies.
Bottalico B; Larsson I; Brodszki J; Hernandez-Andrade E; Casslén B; Marsál K; Hansson SR
Placenta; 2004 Jul; 25(6):518-29. PubMed ID: 15135235
[TBL] [Abstract][Full Text] [Related]
7. Regulation of drug transporter expression and function in the placenta.
Staud F; Ceckova M
Expert Opin Drug Metab Toxicol; 2015 Apr; 11(4):533-55. PubMed ID: 25600150
[TBL] [Abstract][Full Text] [Related]
8. Transporters and their impact on drug disposition.
Beringer PM; Slaughter RL
Ann Pharmacother; 2005 Jun; 39(6):1097-108. PubMed ID: 15886292
[TBL] [Abstract][Full Text] [Related]
9. Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity.
Hakkola J; Pelkonen O; Pasanen M; Raunio H
Crit Rev Toxicol; 1998 Jan; 28(1):35-72. PubMed ID: 9493761
[TBL] [Abstract][Full Text] [Related]
10. Expression and function of p-glycoprotein in normal tissues: effect on pharmacokinetics.
Staud F; Ceckova M; Micuda S; Pavek P
Methods Mol Biol; 2010; 596():199-222. PubMed ID: 19949926
[TBL] [Abstract][Full Text] [Related]
11. Human placenta: a human organ for developmental toxicology research and biomonitoring.
Myllynen P; Pasanen M; Pelkonen O
Placenta; 2005 May; 26(5):361-71. PubMed ID: 15850640
[TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein in the placenta: expression, localization, regulation and function.
Ceckova-Novotna M; Pavek P; Staud F
Reprod Toxicol; 2006 Oct; 22(3):400-10. PubMed ID: 16563694
[TBL] [Abstract][Full Text] [Related]
13. Distribution of glutamate transporters in the human placenta.
Noorlander CW; de Graan PN; Nikkels PG; Schrama LH; Visser GH
Placenta; 2004 Jul; 25(6):489-95. PubMed ID: 15135231
[TBL] [Abstract][Full Text] [Related]
14. Validation of in vitro cell models used in drug metabolism and transport studies; genotyping of cytochrome P450, phase II enzymes and drug transporter polymorphisms in the human hepatoma (HepG2), ovarian carcinoma (IGROV-1) and colon carcinoma (CaCo-2, LS180) cell lines.
Brandon EF; Bosch TM; Deenen MJ; Levink R; van der Wal E; van Meerveld JB; Bijl M; Beijnen JH; Schellens JH; Meijerman I
Toxicol Appl Pharmacol; 2006 Feb; 211(1):1-10. PubMed ID: 15975613
[TBL] [Abstract][Full Text] [Related]
15. Placental transport of thyroid hormone.
James SR; Franklyn JA; Kilby MD
Best Pract Res Clin Endocrinol Metab; 2007 Jun; 21(2):253-64. PubMed ID: 17574007
[TBL] [Abstract][Full Text] [Related]
16. Tobacco smoke-dependent changes in cytochrome P450 1A1, 1A2, and 2E1 protein expressions in fetuses, newborns, pregnant rats, and human placenta.
Czekaj P; Wiaderkiewicz A; Florek E; Wiaderkiewicz R
Arch Toxicol; 2005 Jan; 79(1):13-24. PubMed ID: 15448981
[TBL] [Abstract][Full Text] [Related]
17. The fate and effects of xenobiotics in human placenta.
Myllynen P; Pasanen M; Vähäkangas K
Expert Opin Drug Metab Toxicol; 2007 Jun; 3(3):331-46. PubMed ID: 17539742
[TBL] [Abstract][Full Text] [Related]
18. Functional expression of sinusoidal drug transporters in primary human and rat hepatocytes.
Jigorel E; Le Vee M; Boursier-Neyret C; Bertrand M; Fardel O
Drug Metab Dispos; 2005 Oct; 33(10):1418-22. PubMed ID: 16014767
[TBL] [Abstract][Full Text] [Related]
19. [Barrier role of ABC family of proteins in human placenta].
Kozłowska-Rup D; Czekaj P
Ginekol Pol; 2011 Jan; 82(1):56-63. PubMed ID: 21473056
[TBL] [Abstract][Full Text] [Related]
20. Transporters as a determinant of drug clearance and tissue distribution.
Shitara Y; Horie T; Sugiyama Y
Eur J Pharm Sci; 2006 Apr; 27(5):425-46. PubMed ID: 16488580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
